Four in Five Cancer Patients Require Molecular Testing for Treatment Matching

Recent findings indicate that 80% of cancer patients need molecular tests to accurately characterize their cancers. This raises concerns about whether health systems can effectively provide these tests to match patients with appropriate treatments based on the molecular features of their disease.

Originally published by gnews